🇫🇷 🎯QUERY: Is obturator foramen bypass (OFB) still a durable and viable extra-anatomic option for hostile groin infections? 🩺🦵 This original research published in #EJVESForum by Pascucci et al. evaluates 26 consecutive obturator foramen bypass procedures over a 22-year period at Henri Mondor University Hospital, highlighting its long-term patency and role in complex septic groin management. 💡KEY FINDINGS: · Indications & Patient Profile: Conducted on 26 patients (mean age 64 years; 69% men). The primary indication was extensive groin infection involving native vessels or prosthetic material (81%), with 23% performed under emergency conditions for hemorrhagic shock. · Graft Selection: Cryopreserved arterial allografts were the primary conduit of choice (62%), followed by great saphenous veins (15%) and superficial femoral veins (11%). · Patency & Limb Salvage: Primary patency rates were 88% at 12 months and 83% at 24–60 months. Complete wound healing was achieved in all surviving patients (median delay of six months). · Infection Control & Durability: There were zero cases of bypass re-infection requiring removal during the follow-up period. Limb salvage was achieved in all but one patient. · Early Mortality & Complications: Thirty-day mortality was 15%, reflecting the critical initial clinical condition and severe septic or hemorrhagic presentation of these patients. Early re-interventions were required in 31% of cases, mostly for local wound debridement. 🚀 TAKEAWAY: Demystifying a Life- and Limb-Saving Technique Despite historical perceptions of technical complexity, obturator foramen bypass offers excellent long-term patency and infection-free durability. It remains an essential, reliable extra-anatomic revascularization strategy for severely hostile groins when managed in experienced centers. Read the full Open Access article by Pascucci et al. online 👇 ejvesvascularforum.com/artic… #EJVESforum #VascTwitter #VascularSurgery #GroinInfection #ExtraAnatomicBypass #ObturatorBypass #MedEd @vascularis @bazinger_z @FLareyre @MariaKatsarou14 @NicLeoneMD @ESVSmembership @EVST_ESVS

Look out for the team of editors and reviewers associated with the #EJVESforum @EJVES_ESVS - come and meet us at the booth (or anywhere else at #ESVS2026 if you spot us ) - to talk about submitted papers, projects to consider, advice on getting your papers published, and even if you are thinking of becoming a reviewer!! @bazinger_z @FLareyre @NicLeoneMD @vascularis

A timely reminder as the 2024 Journal Impact Factor for the #EJVESforum is now 1.8, continuing on its upward trajectory! @bazinger_z @FLareyre @arossnaylor @MariaKatsarou14 @MelVegCen

The #EJVESforum booth is open, Interested visitors already dropping by for a chat and a cup of coffee!! Come and see us again after the #ESVS2024 prize session!

COME AND VISIT THE #EJVESforum #ESVS2024 BOOTH!! The Editor-in-Chief @vascularis will be there from 1300 to 1430 to explain how the journal works, what sort of papers we are looking for, the interactions between the 2 journal platforms, and you can browse through the #EJVESflipbook on the nice little workstations!! We are just next to the registration area. @ESVSmembership @EVST_ESVS

Celebrating with this new #EJVESEditorial that the "EJVES Vascular Forum Gets a Journal Impact Factor, Not Just a JIFfy!" 🎉🎉 Congratulations to the fantastic team behind the hard work! @MelVegCen @vascularis @LejayAnne @bazinger_z #EJVESforum 🌐 doi.org/10.1016/j.ejvs.2023.…

Aortic ectasia conveys low risk of AAA related death but significant risk of cancer and CV events. Check out the complete data at a glance in our #EJVESvisualabstract and read the full text #openaccess paper in: ejves.com/article/S1078-5884… #EJVESforum @bazinger_z @MelVegCen